It seems Roche 's stock trades with a discount. Most of the analysts mean the stock is cheap at this level. Currently the company is being followed by 21 analysts. The recommendations are: 4 times sell, 6 times hold and no buys. The average of the target prices for the stock equals 261,05 CHF. This is around 2 percent more than the current price of 259,1 CHF. Liberum, JP Morgan and UBS recently provided recommendations for the stock.
Roche 's market capitalization is based on the number of outstanding shares around 179,28 billion CHF. The Roche stock was the past 12 months quite volatile. Since last December the stock is 8 percent higher. This year the stock price moved between 206 and 259 CHF. Since 2008 the stock price is almost 53 percent higher.
At 14.09 the stock trades 0,29 percent lower at 259,1 CHF.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.